$10.90+0.09 (+0.83%)
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States.
LifeStance Health Group, Inc. in the Healthcare sector is trading at $10.90 with a market capitalization of $3.3B. Wall Street consensus targets $11.70 (10 analysts), implying a +7.3% move over the next 12 months. The stock is currently near its 52-week high of $11.76, remaining 49.7% above its 200-day moving average. On fundamentals, Piotroski 9/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $403.48M↑ | $382.19M↑ | $363.81M↑ | $345.31M↑ | $332.97M |
| Gross Profit | $135.93M↑ | $126.30M↑ | $116.58M↑ | $108.43M↓ | $109.79M |
| Operating Income | $22.28M↑ | $18.08M↑ | $7.41M↑ | -$2.95M↓ | $1.60M |
| Net Income | $14.24M↑ | $11.67M↑ | $1.08M↑ | -$3.79M↓ | $709,000 |
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services...
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.
Does LifeStance Health Group (LFST) have what it takes to be a top stock pick for momentum investors? Let's find out.
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
ENSG expands its Texas footprint with two skilled nursing acquisitions, adding 250 licensed beds and strengthening its owned real estate portfolio.